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Introduction
Delirium is an acute neuropsychiatric disorder characterized by a disturbance in attention and awareness, which develops over a short period of time, with additional disturbance in cognition which are not explained by a pre-existing cognitive impairment. Delirium that occurs in patients with dementia is referred to as delirium superimposed on dementia (DSD). 1 People who are older with dementia and who are institutionalized are at increased risk of developing delirium when hospitalized. In addition, their prior cognitive impairment makes detecting their delirium a challenge. The prevalence of DSD in institutionalized patients ranges from 1.4% to 70% according to the diagnostic tools, 2 while the prevalence in community and hospital populations ranges from 22% to 89%. 1 It is associated with higher health care costs, worse functional outcomes, and higher mortality rates when compared to patients with dementia alone. 1, [3] [4] [5] [6] It was estimated that 35.6 million people lived with dementia worldwide in 2010, with the prevalence expected to nearly double every 20 years, to 65 million in 2030 and 115 million in 2050. 7 Therefore, DSD by inference will affect millions of people worldwide especially in nursing home facilities.
The diagnosis of delirium currently relies on the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) and the International Classification of Disease-10 ( Table 1) . 8, 9 These two standard references are similar in the definition of delirium, but it should be noted that no specific criteria are provided to clinicians or researchers in either system to assist with the diagnosis of DSD. The DSM-5 specifies that the cognitive deficits should not be better explained by a pre-existing, established or evolving neurocognitive disorder. In the ICD-10 preexisting cognitive deficits are not considered.
Thirty years ago Lipowski provided a reference work for the definition of the concept of delirium. 10 During the following years several terms have been used to define delirium. There has been an attempt to reduce the heterogeneity of delirium terminology to avoid "confusion" in clinical work and especially in research studies. The challenge to achieve clarity is even greater when delirium is considered in patients with preexisting dementia. In this context several terms have been used: sundowning, acute dementia, rapidly progressive dementia, acute confusion, delirium in cognitively impaired patients, and delirium superimposed on dementia. 11 While dementia may have more consistent terminology, the breadth of cognitive impairments in dementia nonetheless makes the assessment of baseline (and incident changes) in cognitive function challenging. While some advocates prefer standardized testing, the progressive nature of dementia limits the battery of tests available. Additionally, the growing diversity of the world population and the increasing challenge of dementia worldwide necessitate the availability of assessments in languages other than English.
The lack of standardization in the assessment of DSD may have potential significant clinical and research implications. Neither the DSM-5 nor the ICD-10 provide clinicians with indications of specific tests for assessment of attention or additional cognitive disturbances in cognition or altered level of arousal. Importantly, the assessment or inclusion of pre-existing cognitive impairment is also not addressed by either the DSM-5 or ICD-10. Meagher and colleagues have recently attempted to provide a standardized approach to the use of the DSM-5 criteria for delirium to avoid "confusion" even with the use of the standard reference.
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As the DSM-5 and the ICD-10 are considered the standard reference for the diagnosis of delirium, then several practical limitations should be considered.
First, attention has multiple domains 13 and there is not a clear DSM-5 and ICD-10 guidance regarding which domain or attention test should be used in patients with dementia, dementia stage, or dementia subtypes.
Second, the clinician is currently not provided with clear and predetermined methodology for how to ascertain the time of onset of delirium, the change from baseline, and fluctuation over the course of the day.
Third, there is no reference for how to determine the presence of a pre-existing neurocognitive disorder or the level of arousal.
As a result, we formed a task force of EDA (European Delirium Association;
www.europeandeliriumassociation.com), ADS (American Delirium Association;
www.americandeliriumsociety.org), and AADA (Australasian Delirium Association;
www.delirium.org.au) society members, collectively called iDelirium (www.idelirium.org), to a) clarify the key elements for the diagnosis of DSD, b) review evidence of DSD diagnosis, and c) formulate a path for the future direction of research in DSD.
1. The challenge of neuropsychological assessment of delirium in dementia patients
1.a) Attention deficits
Inattention is considered a core feature of delirium (Criterion A, DSM-5) and a valid assessment of attention is therefore central to the diagnosis.
Definition of attention
Attention is widely studied in neuropsychology but there is not a single definition. A possible definition proposed by Cohen is the "ability to focus on a selected stimulus, sustaining that focus and shifting it at will." 14 Three major functions of attention are (a) orienting to sensory events, (b) detecting signals for focal processing, and (c) maintaining a vigilant or alert state. 13, 15 These are reflected to some extent in the DSM-5 criteria for delirium, which state that patients must demonstrate a 'reduced ability to direct, focus, sustain and shift attention. 8 However, elements of executive function fall under the umbrella name of inattention and include much higher level cognitive tasks that are likely to be impaired in dementia such as shifting and divided attention (multitasking).
Attentional deficits in delirium and dementia
The extent to which different aspects of attention are affected in delirium is poorly understood.
Marked impairments in focusing and sustaining attention (i.e. the ability to maintain attention to stimuli over time) are considered the hallmark feature of delirium. [16] [17] [18] One of the key challenges of delirium diagnosis is that the severity of attentional deficits in delirium varies greatly between patients (and also sometimes within the same patient at different time points), ranging from subtle impairments in complex working memory tasks, to more pronounced deficits in orienting and focusing attention, and finally to a state of lowered level of arousal whereby patients are unable to respond to simple commands. DSM-5 does not offer some guidance, as it states that an inability to engage in standardized testing or interview should be classified as severe inattention. 19 Complex attentional impairments may be found in the early stages of Alzheimer's Disease (AD) dementia (without delirium), but overall the ability to focus and sustain attention is relatively preserved in the earlier stages of AD. 20 Conversely it has been shown that sustained, divided and selected attention are compromised in the moderate to severe stages of dementia. 21 The type of dementia is also a factor. For example, patients with Lewy Body dementia have considerably greater impairment of attention compared to patients with another type of dementia. 22 Given the centrality of inattention to the definition of delirium, much more needs to be learned about the nature of attentional deficits in both dementia and delirium if criteria for the diagnosis of DSD are to be optimized.
Tests to evaluate inattention
There is no consensus on how attention should be assessed, 23 and most existing tests differentiate the inattention found in delirium from that in dementia. 24, 25 This uncertainty impedes progress in clinical practice and research. Several neuropsychological tests are currently used to assess inattention in delirium including digit span, spatial span, months of the year and days of the week backwards, and serial sevens. 18 A recent review of studies on attention assessment in delirium concluded that cancellation tests (i.e., test to determine an individual's ability to detect targets amongst a range of similar stimuli, usually digits or letters), span tests and computerized tests of sustained attention appear to offer utility in discriminating delirium from dementia. 18 Months of the year backwards, one of the most widely used attention test in clinical practice, appears to have high sensitivity to delirium in older hospitalized patients. [26] [27] [28] In general, caution is warranted when generalizing these findings. Further, tests are often labeled as measuring inattention when they also depend on other cognitive components, which themselves are more likely to be affected in dementia. There is an overlap of attention, working memory, and executive control. For instance, digit span is used as a measure of inattention but it is also used to measure executive functiong and working memory. Cognitively simple tests that rely on focusing and sustaining attention rather than manipulating information or testing memory may be especially useful in discriminating delirium from dementia. Clearly the ability to engage cognition depends on the degree of arousal ( Figure 2 ). The term "arousal" can be defined as the level of sensory stimulation that is required to keep the patient attending to the examiner's question or following a command. 30 The key role of arousal in delirium was first recognized over three decades ago and is now well established. In 1980 the Diagnostic and Statistical Manual of Mental Disorders (DSM) III version indicated that impaired consciousness was a core symptom of delirium, and this criterion was confirmed in subsequent years by almost all the classification systems. In what seems to be a reversal in this guidance, the current DSM-5 places greater emphasis on awareness, attention, and other cognitive disorders while de-emphasizing consciousness . 8 Indeed, Criterion D of DSM-5 criteria state that inattention and changes in cognition must not occur in the context of a severely reduced level of arousal such as coma. Far from being a downgrading of the role of arousal in delirium, these criteria implicitly admit that arousal disorders are an integral aspect of this condition. 31 In fact, both attention and arousal are hierarchically related: it is possible to have full arousal, but profound inattention (for example, hypervigilance), but not the other way around, 32 (i.e., when disorders of arousal exist inattention is always present). 31 In other words, the DSM-5 criteria identify a threshold (i.e., coma) under which a patient cannot be regarded as delirious, but does not reject the role of arousal in delirium phenomenology. 31 Leonard and colleagues 33 have reported that delirium may be distinguished from dementia by virtue of the disproportionate impairment of vigilance and attention. Importantly, arousal is generally preserved in advanced chronic cognitive disorders, 16 while attention and cognition (i.e., orientation, memory, language and executive functions) are usually already impaired in the moderate stages of dementia 26, 34 and especially when dementia is severe. 35 A pathophysiological explanation relies on evidence that performance on attentional and general cognitive tasks, when administered, is contingent on brain activity in distributed cortical areas 36 which are generally damaged in the advanced stages of dementia, while arousal assessment tests structures in the brainstem. 37 Because the hierarchical pattern of neurodegeneration in Alzheimer's disease begins in the entorhinal/perirhinal cortex, then progresses in the hippocampus and in association cortex, and finally in the primary neocortex (NIA-RI Consensus 1997), it could be hypothesized that attentional and other cognitive tasks can not be assessed when the damage in the brain is advanced. On the contrary, arousal assessment may be feasible when dementia is severe. To indirectly support this observation, it is not surprising that studies to discriminate neuropsychological profiles of delirious and demented patients have generally recruited individuals with mild or, at most, moderate stages of dementia.
Tieges and colleagues developed a new approach with the Observational Scale of Level of Arousal OSLA 38 , to detect delirium by observing eye opening, eye contact, as well as patient posture and movement. Delirium is not an isolated mental disorder, but affects motor function as well. 39, 40 The evaluation of posture and movement might indeed be of interest in the context of patients with dementia. A study comparing 4 groups of 15 patients (with delirium alone, with dementia alone, with delirium superimposed on dementia and with neither delirium nor dementia)
found that when delirium develops, a worsening of motor performance also occurs. 40 In patients with pre-existing dementia, the resolution of delirium did not result in a significant improvement of specific cognitive functions, providing indirect evidence that when dementia is advanced, the cognitive testing does not provide good information to support the diagnosis of delirium. In this case, an assessment of motor abilities may assume a more specific diagnostic utility. 40 In this regard, the Richmond Agitation and Sedation Scale (RASS), 41 , 42 a scale originally evaluated to monitor the level of consciousness in critically ill patients, might provide important information on motor fluctuations given its potential to identify motor subtypes of delirium.
Negative scores on the RASS may indicate hypoactive behavior in delirium, and a positive scores indicative of a hyperactive behavior. The scale has been recently modified and adapted for use in general wards (i.e. the modified RASS or m-RASS). 43 Both the RASS and the m-RASS are ultrabrief assessments of the level of consciousness and recent studies have suggested that they have high specificity for delirium in geriatrics wards, emergency department 38, 43, 44 and specifically in patients with dementia. 45 It could therefore be hypothesized that when dementia is severe or very severe, and attention cannot be tested using tools that require a certain level of cognition, arousal and basic motor performance may be routinely assessed to detect delirium. For example, the observation of an unexpected drowsiness or failure to sit up from the bed in patients who were previously alert and able to move could suggest delirium in demented patients. Mobility performances in patients with dementia may similarly be used to detect incipient delirium.
Dementia with Lewy bodies and the influence on tests used to diagnose delirium
The clinical phenotypes of dementias show some overlap with delirium. For example, fluctuating cognition is seen in Alzheimer's disease and vascular dementia; however the prevalence and severity of fluctuation is greatest in dementia with Lewy bodies (DLB). 46 Similarly, complex visual hallucinations and delusions frequently occur in DLB, Parkinson's disease dementia (PDD) and delirium , but are seen in only 4-8% of AD patients. 47 As a result, it is harder to differentiate DLB from delirium in comparison to other dementias according to the key features as identified by
Meagher et al (attentional deficits, sleep-wake cycle disturbance, impaired higher level thinking disturbances). 48 DLB is viewed by many as the most challenging dementia subtype in which to diagnose DSD. 49 There is a pressing need to develop methods to distinguish delirium and DLB. Lewy Body disease is the second most common form of dementia in older people with a prevalence of 15-20% of all dementias at autopsy. 50 The prevalence of older adults with two or more DLB symptoms in nursing homes ranges from 16% to 20%. 51 Furthermore DLB patients also appear to be more acutely sensitive to minor insults (even subclinical events) and thus more delirium "prone".
Consequently, and unsurprisingly, delirium is more commonly diagnosed in DLB than Alzheimer's dementia (AD) 52 with 32% of outpatients with DLB experiencing delirium as opposed to 15% of outpatients with AD. 53 Differentiating DSD from DLB or delirium alone is vital in order to guide initial management and safe prescribing. Incorrectly diagnosing an acute change as a deterioration in patients with existing DLB rather than delirium can result in the under-investigation of common causes of delirium such as infections, medications and pain and inadequate management of this potentially life threatening medical emergency. Conversely, the lack of recognition of undiagnosed DLB in someone with delirium may result in patients being treated with anti-psychotic medications.
Such agents can significantly worsen features of their DLB, such as parkinsonism and cognitive impairment/arousal, and significantly increase the risk of mortality. 54 Furthermore, a failure to diagnosis DLB may mean that patients receive treatments such as cholinesterase inhibitors, which have been shown to improve hallucinations, delusions and cognition in patients with DLB. 55 Given findings that suggest cholinesterase inhibitors might worsen delirium outcomes, 56 it is imperative that an accurate diagnoses of DLB in these settings. Research into how to recognize delirium in people with DLB may also focus on developing methods to test features that are most likely to differ, including cognitive domains such as orientation, vigilance and psychomotor disturbances. 50 Currently, when there is a suspicion of DLB, diagnostic biomarkers such as a DaT SCAN may be helpful, 57 although from a practical point of view, these usually need to be performed after the delirium episode ends. The role of objective biomarkers measurements such as electroencephalography (EEG) to distinguish delirium and DLB, is appealing, however EEG patterns in delirium overlap with those seen in DLB, making the differentiation more difficult. More advanced methods of EEG processing/quantification may illuminate other specific nuances between delirium and DLB and could provide a focus for future research.
Framework for improving the diagnosis of DSD
There are many gaps in our knowledge about how to diagnose DSD with a high degree of accuracy.
The current state of the science does not provide guidance on which clinical tests and biomarkers should be specifically tested in DSD patients. Additional challenges are related to the possible difference in DSD presentation in patients with different types of dementia (Figure 1 ).
Here we provide a consensus from the iDelirium group on research that is needed to clarify important key points in the diagnosis of DSD (Table 3) . 
Improving Attention testing

Clinical evaluation of DSD
Define a specific protocol to collect information from family members, review of medical records, to determine basic and instrumental activities of daily living, and to determine prior cognitive function using a standardized collateral informant questionnaire such as the the SF-IQCODE or the AD8.
Clinical exam
Define which component of the neurological exam might be useful or indicative in the diagnosis of DSD e.g., tendon reflexes, plantar reflexes, UPM/extrapyramidal, archaic reflexes, myoclonia; eye examination including pupil size, light reflex, oculocephalic response; cough reflex, grimace. 
Laboratory testing
Summary
Delirium superimposed on dementia is a clinical syndrome that can result in very poor outcomes.
Accurate identification has so far been elusive. In this report, we have presented descriptions of its presentation and associated clinical findings, and the insufficiency of current diagnostic assessment tools. We hope that our framework will be helpful for the improved delineation of this highly problematic geriatric clinical syndrome. Table 1 : DSM-5 and ICD-10 diagnosis of delirium Table 2 : Delirium and Dementia with Lewy bodies: overlap and differences Table 3 : Framework for improving the diagnosis of delirium superimposed on dementia (DSD). There is evidence from the history, physical examination or laboratory findings that the disturbance is a direct physiological consequence of another medical condition, substance intoxication or withdrawal, or exposure to a toxin, or is due to multiple etiologies.
Legend tables and figures
Objective evidence from history, physical and neurological examination, or laboratory tests of an underlying cerebral or systemic disease (other than psychoactive substance-related) that can be presumed to be responsible for the clinical manifestations. 
